Home > Healthcare > Medical Devices > Implantable Devices > Elbow Replacement Market

Elbow Replacement Market Analysis

  • Report ID: GMI8267
  • Published Date: Feb 2024
  • Report Format: PDF

Elbow Replacement Market Analysis

The market by product is categorized into total elbow replacement, partial elbow replacement, and revision elbow replacement. The total elbow replacement segment garnered USD 145.2 million revenue in 2023.
 

  • The prevalence of elbow arthritis, including rheumatoid arthritis and post-traumatic arthritis, is growing worldwide. Arthritis damages the elbow joint over time, causing discomfort, swelling, and a reduced range of motion. Total elbow replacement is an effective treatment option for individuals with chronic arthritis that have exhausted conservative treatments. As per the National Health Interview Survey (NHIS), from 2019 to 2021, in U.S., the overall number of people with arthritis was 24.2% among women and 17.9% among men, respectively.
     
  • Furthermore, the demand for minimally invasive surgical instrument in total elbow replacement has increased in recent years. Minimally invasive approaches involve smaller incisions, reduced tissue trauma, and faster recovery times compared to traditional open surgery. Patients benefit from less post-operative pain, shorter hospital stays, and quicker return to daily activities. This is anticipated to boost the segmental growth in the market positively.
     
Elbow Replacement Market, By Material Type (2023)

Based on material type, the elbow replacement market is segmented into cobalt-chromium alloys, titanium alloys, stainless steel, and other materials. The cobalt-chromium alloys segment accounted for 51.5% business share in 2023 and is anticipated to witness significant growth during the forecast period.
 

  • Cobalt-chromium alloys exhibit excellent biocompatibility, making them suitable for use in orthopedic implants. These alloys have low reactivity and corrosion resistance properties, which minimize the risk of adverse tissue reactions and implant-related complications following elbow replacement surgery.
     
  • Moreover, it possess high strength, hardness, and wear resistance, making them well-suited for load-bearing applications in the elbow joint. These mechanical properties enable cobalt-chromium implants to withstand the forces and stresses encountered during daily activities, thereby ensuring long-term durability and stability of the implant.
     

Based on indication, the elbow replacement market is segmented into osteoarthritis, post-traumatic arthritis, rheumatoid arthritis, fracture, and other indications. The osteoarthritis segment dominated the market and accounted for 46.2% business share in 2023.
 

  • Continuous advancements in surgical techniques, implant materials, and rehabilitation protocols have made elbow replacement surgery a viable option for patients with severe osteoarthritis. These advancements have widened the eligible patient population and contributed to the growth of osteoarthritis as a leading indication for elbow replacements.
     
  • Additionally, favorable reimbursement policies from insurance providers and government healthcare programs for joint replacement surgeries, particularly for osteoarthritis, incentivize both patients and healthcare providers to opt for surgical interventions, further enhancing its market share.
     

The elbow replacement market by end-use is categorized into hospitals, orthopedic clinics, and ambulatory surgical centers. The hospitals segment accounted for around USD 132.7 million revenue size in 2023.
 

  • Growing awareness among patients about the benefits of joint replacement surgeries, including elbow replacement, coupled with increased acceptance of surgical interventions, has led to a higher number of procedures being performed in hospital settings.
     
  • Advancements in implant materials, surgical techniques, and prosthetic design have made elbow replacement surgeries more effective, safer, and with better outcomes, encouraging more hospitals to offer these procedures. These factors collectively contribute to the growth of the market specifically within hospital settings.
     
North America Elbow Replacement Market, 2020 – 2032 (USD Million)

North America elbow replacement market accounted for USD 98.1 million revenue in 2023 and is predicted to witness substantial market growth.
 

  • In North America, the market is thriving due to several key factors. Firstly, the region hosts major orthopedic implant manufacturers and specialized healthcare providers, fostering a competitive landscape that drives innovation and market expansion.
     
  • The regions significant aging population, prone to degenerative joint diseases such as osteoarthritis, fuels demand for joint replacement surgeries, including elbow replacements. This demographic trend is a primary driver of market growth as the need for surgical interventions escalates with age.
     
  • Moreover, the presence of comprehensive health insurance coverage and favorable reimbursement policies incentivizes patients to opt for joint replacement procedures. This financial support encourages higher procedure rates, consequently boosting the market for elbow replacements.
     
  • Advancements in implant materials, surgical techniques, and prosthetic designs have significantly enhanced the outcomes of elbow replacement surgeries. As a result, these technological innovations attract more patients seeking effective treatment options and contribute to the overall expansion of the market.
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global elbow replacement industry was valued at around USD 244.4 million in 2023 and is estimated to reach over USD 474 million by 2032, attributed to the ongoing advancements in technology, an increasing incidence of elbow injuries, and a rising demand for minimally invasive procedures.

The total elbow replacement segment garnered USD 145.2 million in 2023 and will grow through 2032 as it is an effective treatment option for individuals with chronic arthritis that have exhausted conservative treatments.

North America elbow replacement industry accounted for over USD 98.1 million in 2023 and is predicted to witness substantial growth through 2032 as the region hosts major orthopedic implant manufacturers and specialized healthcare providers.

Acumed LLC., Arthrex, Inc., DJO, LLC, Johnson & Johnson (DePuy Synthes), Limacorporate S.p.A., ORTHOFIX MEDICAL INC, Ottobock, Stryker Corporation, Wright Medical Group N.V., and Zimmer Biomet Holdings, Inc.

Elbow Replacement Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 208
  • Countries covered: 22
  • Pages: 110
 Download Free Sample